Ondansetron ODT 8 mg

ondansetron · Ranbaxy Laboratories Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ondansetron ODT 8 mg, covering 2012-02-09 to 2012-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions [NA]